The Medical Device Innovation Consortium (MDIC) announced Pamela Goldberg, MBA, as President and Chief Executive Officer of MDIC. Ms. Goldberg joins MDIC following her most recent tenure as an independent consultant. Ms. Goldberg also brings with her extensive experience from her time as CEO at the Massachusetts Technology Collaborative, a public economic development agency, where she worked closely with industry, academic, and government leaders to advance technology-based solutions with specific focus on digital health, data analytics, robotics, and cybersecurity.
In accepting the position as Chief Executive Officer, Ms. Goldberg said, “I am excited by the opportunity to lead the MDIC team. I look forward to engaging with our members across the medical technology spectrum to continue to advance the MDIC mission by driving best practices to promote medical device innovation from concept to commercialization while continuing to enhance patient access and safety.”
NESTcc is excited to welcome Pamela to the MDIC team and looks forward to the path ahead for MDIC and NESTcc. Access the full MDIC press release to learn more about Pamela, her career, and her decision to join MDIC.
About the National Evaluation System for health Technology Coordinating Center
In 2016, the U.S. Food and Drug Administration (FDA) awarded the Medical Device Innovation Consortium (MDIC) $3 million in seed funding to establish the National Evaluation System for health Technology Coordinating Center (NESTcc). The Coordinating Center seeks to support the sustainable generation and use of timely, reliable, and cost-effective Real-World Evidence (RWE) throughout the medical device lifecycle, using Real-World Data (RWD) that meets robust methodological standards and is generated in the course of clinical care and everyday life by patients, providers, or payers, and for the purpose of enhancing regulatory and clinical decision-making. For more information, visit http://www.nestcc.org.
About the Medical Device Innovation Consortium
Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. MDIC works in the pre-competitive space to facilitate development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market. For more information, visit http://www.mdic.org.